Page 121 - GPD-4-1

Gene & Protein in Disease Prognostic role of SIRT1 expression in cancer

doi: 10.1002/cam4.310 modifications predicts clinical outcome in colorectal cancer.
Histopathology. 2015;66(2):270-282.
13. Lee CW, Wong LL, Tse EY, et al. AMPK Promotes p53
acetylation via phosphorylation and inactivation of SIRT1 doi: 10.1111/his.12534
in liver cancer cells. Cancer Res. 2012;72(17):4394-4404.
25. Li C, Wang L, Zheng L, et al. SIRT1 expression is associated
doi: 10.1158/0008-5472.CAN-12-0429 with poor prognosis of lung adenocarcinoma. Onco Targets
14. Zhang H, Ma C, Peng M, Lv X, Xie X, Huang R. The Ther. 2015;8:977-984.
prognostic implications of SIRTs expression in breast doi: 10.2147/OTT.S82378
cancer: A systematic review and meta-analysis. Disc Oncol.
2022;13(1):69. 26. Grbesa I, Pajares MJ, Martinez-Terroba E, et al. Expression of
sirtuin 1 and 2 is associated with poor prognosis in non-small
doi: 10.1007/s12672-022-00529-7 cell lung cancer patients. PLoS One. 2015;10(4):e0124670.
15. Wang C, Yang W, Dong F, et al. The prognostic role of doi: 10.1371/journal.pone.0124670
Sirt1 expression in solid malignancies: A meta-analysis.
Oncotarget. 2017;8(39):66343-66351. 27. Zhang X, Chen S, Cheng M, Cao F, Cheng Y. The expression
and correlation of SIRT1 and Phospho-SIRT1 in colorectal
doi: 10.18632/oncotarget.18494 cancer. Int J Clin Exp Med. 2015;8(1):809-817.
16. Cao YW, Li YC, Wan GX, Du XM, Li F. Clinicopathological 28. Teramae M, Fukuda T, Wada T, et al. Sirtuin1 expression
and prognostic role of SIRT1 in breast cancer patients: predicts the efficacy of neoadjuvant chemotherapy for
A meta-analysis. Int J Clin Exp Med. 2015;8(1):616-624. locally advanced uterine cervical cancer. Mol Clin Oncol.
17. Sun M, Du M, Gong X. Survival and clinicopathological 2015;3(1):73-78.
significance of SIRT1 expression in cancers: A meta- doi: 10.3892/mco.2014.427
analysis. Front Endocrinol. 2019;10:442007.
29. Qiu G, Li X, Wei C, et al. The prognostic role of
18. Otsuka R, Sakata H, Murakami K, et al. SIRT1 expression is SIRT1-autophagy axis in gastric cancer. Dis Markers.
a promising prognostic biomarker in esophageal squamous 2016;2016(1):6869415.
cell carcinoma: A systematic review and meta-analysis.
Cancer Diagn Prog. 2022;2(2):126-133. doi: 10.1155/2016/6869415
doi: 10.21873/cdp.10086 30. Szász AM, Lánczky A, Nagy Á, et al. Cross-validation
of survival associated biomarkers in gastric cancer
19. Zhang YL, Chen P, Guo Y, Zhang YJ. Clinical value of using transcriptomic data of 1,065 patients. Oncotarget.
SIRT1 as a prognostic biomarker in esophageal squamous 2016;7(31):49322.
cell carcinoma, a systematic meta-analysis. Open Med.
2022;17(1):527-535. doi: 10.18632/oncotarget.10337
doi: 10.1515/med-2022-0454 31. Chung SY, Jung YY, Park IA, et al. Oncogenic role of SIRT1
associated with tumor invasion, lymph node metastasis, and
20. Jung W, Hong KD, Jung WY, et al. SIRT1 expression is poor disease-free survival in triple negative breast cancer.
associated with good prognosis in colorectal cancer. Korean Clin Exp Metastasis. 2016;33:179-185.
J Pathol. 2013;47(4):332-339.
doi: 10.1007/s10585-015-9767-5
doi: 10.4132/KoreanJPathol.2013.47.4.332
32. Jeh SU, Park JJ, Lee JS, et al. Differential expression of
21. Zhou J, Xu M, Le K, et al. SRC promotes tamoxifen resistance the sirtuin family in renal cell carcinoma: aspects of
in breast cancer via up-regulating SIRT1. Onco Targets Ther. carcinogenesis and prognostic significance. Urol Oncol.
2020;13:4635-4647. 2017;35:675-e79.
doi: 10.2147/OTT.S245749 doi: 10.1016/j.urolonc.2017.08.016
22. Tan J, Liu Y, Maimaiti Y, et al. Combination of SIRT1 and Src 33. Mvunta DH, Miyamoto T, Asaka R, et al. Overexpression
overexpression suggests poor prognosis in luminal breast of SIRT1 is associated with poor outcomes in patients with
cancer. Onco Targets Ther. 2018;11:2051-2061. ovarian carcinoma. Appl Immunohistochem Mol Morphol.
doi: 10.2147/OTT.S162503 2017;25(6):415-421.
23. Ryota O, Hiroki M, Keiko I, et al. Serum versus tissue doi: 10.1097/PAI.0000000000000316
SIRT1 as potentially valuable biomarkers in gastric cancer. 34. Gharabaghi MA. Diagnostic investigation of BIRC 6 and
Anticancer Res. 2023;43(4):1485. SIRT 1 protein expression level as potential prognostic
doi: 10.21873/anticanres.16297 biomarkers in patients with non‐small cell lung cancer. Clin
Respir J. 2018;12(2):633-638.
24. Benard A, Goossens‐Beumer IJ, van Hoesel AQ, et al.
Nuclear expression of histone deacetylases and their histone doi: 10.1111/crj.12572

Volume 4 Issue 1 (2025) 13 doi: 10.36922/gpd.4294